Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 3 (2008), Issue 4 (April)

1. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
   Hepatology, 47(4): 1118-27. [Abstract] [Full-text]
2. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
   Intervirology, 51(1): 59-68. [Abstract] [Full-text]
3. Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
   Hepatology, 47(4): 1128-35. [Abstract] [Full-text]
4. Health-related quality of life in chronic hepatitis B patients.
   Hepatology, 47(4): 1108-17. [Abstract] [Full-text]
5. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
   Hepatology, 47(4): 1223-32. [Abstract] [Full-text]
6. Hepatitis C genotype 4: What we know and what we don't yet know.
   Hepatology, 47(4): 1371-83. [Abstract] [Full-text]
7. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
   Hepatology, 47(4): 1136-49. [Abstract] [Full-text]
8. Modelling hepatitis C virus kinetics during treatment with pegylated interferon alpha-2b: errors in the estimation of viral kinetic parameters.
   J Viral Hepat, 15(5): 357-62. [Abstract] [Full-text]
9. Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003.
   J Med Virol, 80(5): 798-802. [Abstract] [Full-text]
10. Case report: Rift Valley Fever with vertical transmission in a pregnant Sudanese woman.
    J Med Virol, 80(5): 929. [Abstract] [Full-text]
11. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy.
    J Med Virol, 80(5): 833-40. [Abstract] [Full-text]
12. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.
    J Med Virol, 80(5): 824-32. [Abstract] [Full-text]
13. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand.
    J Med Virol, 80(5): 808-15. [Abstract] [Full-text]
14. Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods.
    J Med Virol, 80(5): 803-7. [Abstract] [Full-text]
15. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.
    J Med Virol, 80(5): 791-7. [Abstract] [Full-text]
16. Acute hepatitis A virus infection in Turkey.
    J Med Virol, 80(5): 785-90. [Abstract] [Full-text]
17. Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006.
    J Med Virol, 80(5): 777-84. [Abstract] [Full-text]
18. Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon alpha-2b.
    J Viral Hepat, 15(5): 379-82. [Abstract] [Full-text]
19. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    J Viral Hepat, 15(5): 339-45. [Abstract] [Full-text]
20. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
    J Viral Hepat, 15(5): 323-30. [Abstract] [Full-text]
21. A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
    J Viral Hepat, 15(5): 370-8. [Abstract] [Full-text]
22. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
    J Viral Hepat, 15(5): 363-9. [Abstract] [Full-text]
23. Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.
    J Viral Hepat, 15(5): 331-8. [Abstract] [Full-text]
24. Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5.
    J Viral Hepat, 15(5): 383-6. [Abstract] [Full-text]
25. Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus.
    J Clin Microbiol, 46(4): 1268-73. [Abstract] [Full-text]
26. Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B.
    J Clin Microbiol, 46(4): 1517-9. [Abstract] [Full-text]
27. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Clin Gastroenterol Hepatol, 6(4): 459-64. [Abstract] [Full-text]
28. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
    Clin Gastroenterol Hepatol, 6(4): 451-8. [Abstract] [Full-text]
29. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis.
    Clin Gastroenterol Hepatol, 6(4): 379-88. [Abstract] [Full-text]
30. Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
    J Viral Hepat, 15(5): 392-8. [Abstract] [Full-text]
31. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.
    Eur J Haematol, 80(5): 381-5. [Abstract] [Full-text]
32. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Gut, 57(5): 664-71. [Abstract] [Full-text]
33. Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.
    Cancer Lett, 263(2): 212-22. [Abstract] [Full-text]
34. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
    Vox Sang, 94(4): 358-62. [Abstract] [Full-text]
35. Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus-infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks.
    Infect Immun, 76(5): 1866-76. [Abstract] [Full-text]
36. Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.
    Transplantation, 85(8): 1105-11. [Abstract] [Full-text]
37. The Young Men's Survey phase II: hepatitis B immunization and infection among young men who have sex with men.
    Am J Public Health, 98(5): 839-45. [Abstract] [Full-text]
38. Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study.
    Am J Public Health, 98(5): 846-52. [Abstract] [Full-text]
39. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.
    Am J Public Health, 98(5): 853-61. [Abstract] [Full-text]
40. The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.
    Am J Public Health, 98(5): 832-8. [Abstract] [Full-text]
41. Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.
    Nat Clin Pract Oncol, 5(5): 268-78. [Abstract] [Full-text]
42. Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.
    J Virol, 82(10): 5109-14. [Abstract] [Full-text]
43. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.
    J Virol, 82(10): 5043-53. [Abstract] [Full-text]
44. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    J Med Virol, 80(6): 980-8. [Abstract] [Full-text]
45. Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells.
    J Med Virol, 80(6): 989-96. [Abstract] [Full-text]
46. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
    J Med Virol, 80(6): 974-9. [Abstract] [Full-text]
47. Analysis of the entire nucleotide sequence of hepatitis B causing consecutive cases of fatal fulminant hepatitis in Miyagi Prefecture Japan.
    J Med Virol, 80(6): 967-73. [Abstract] [Full-text]
48. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    J Med Virol, 80(6): 960-6. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.